Peters Anomaly: Review of the Literature

Bhandari, Ramanath; Ferri, Sara; Whittaker, Beatrice; Liu, Margaret; Lazzaro, Douglas R.

doi:10.1097/ico.0b013e31820156a9

Cited by 141 publications

(115 citation statements)

References 27 publications

Supporting

Mentioning

110

Contrasting

Unclassified

Order By: Relevance

“…A recently published review of literature reported unilateral disease in 36.8% of 58 cases with Peters anomaly. [10] The rate of unilateral disease, however, was observed in 71.4% of seven patients in this study, but this difference may be attributed to the relatively smaller sample size. Comparably, half of the phakomatoses patients had unilateral disease in this study and this is consistent with published literature which also demonstrate a relatively more even distribution of laterality.…”

Section: Discussioncontrasting

confidence: 58%

Demographic features of subjects with congenital glaucoma

Tamçelik

Atalay

Bölükbaşı

et al. 2014

Indian J Ophthalmol

View full text Add to dashboard Cite

Context:Congenital glaucoma is a potentially blinding ocular disease of the childhood. Identification of the possible associated risk factors and may be helpful for prevention or early detection of this public health problem.Aims:To demonstrate the demographic features of congenital glaucoma subjects.Setting and Design:The charts of congenital glaucoma patients referred to Tamcelik Glaucoma Center were retrospectively reviewed through the dates of 2000 and 2013.Materials and Methods:Analyzed data included diagnosis, age at first presentation, symptoms at first presentation, laterality of the disease, sex, presence of consanguinity, family history of congenital glaucoma, maturity of the fetus at delivery, and maternal age at conception.Statistical Analysis Used:Statistical Package for Social Sciences (SPSS) version 19.0 by IBM (SPSS Inc, Chicago, Illinois, USA) was used to compare the mean of continuous variables with Student's t-test and analysis of variance (ANOVA) and χ2 test was used to test differences in proportions of categorical variables.Results:The data of 600 eyes of 311 patients were analyzed. The distribution of primary and secondary congenital glaucoma among the patients were 63.3% (n = 197) and 36.7% (n = 114), respectively. Of the 311 patients, 57.2% (n = 178) were male and 42.8% (n = 133) were female. The overall frequency of bilateral disease was 92.3% (n = 287). Overall rate of consanguinity and positive family history was 45.3% (n = 141) and 21.2% (n = 66), respectively.Conclusions:Bilateral disease in this study was more common than previously reported studies. Positive family history was more frequent in primary congenital glaucoma although not statistically significant.

show abstract

Section: Discussioncontrasting

confidence: 58%

Demographic features of subjects with congenital glaucoma

Tamçelik

Atalay

Bölükbaşı

et al. 2014

Indian J Ophthalmol

View full text Add to dashboard Cite

show abstract

“…[10][11][12][13] Although success rates as high as 83% have been reported 9 in type 1 Peters anomaly, the management of patients with type 2 Peters anomaly remains a challenge because of the high risk of graft failure. 21,22 Both our patients had type 2 Peters anomaly with a more prominent posterior corneal haze and needed other interventions, such as lensectomy, which have been associated with poor prognosis for PKP in some studies. 12,23 With the advantages of PLK over PKP in mind, we decided to perform DSAEK in our cases for a number of reasons.…”

Section: Discussionmentioning

confidence: 95%

Posterior Lamellar Keratoplasty (DSAEK) in Peters Anomaly

Hashemi

Ghaffari

Mohebi

2012

Cornea

View full text Add to dashboard Cite

show abstract

“…We selected IVB as the first treatment because it could be performed even in an eye with a corneal opacity. Penetrating keratoplasty was not considered before the treatment for ROP because we knew the results are not favorable in patients with Peters anomaly type II [2]. …”

Section: Discussionmentioning

confidence: 99%

“…Peters anomaly is characterized by congenital corneal opacities, defects of the Descemet's membrane, shallow anterior chambers, cataracts, and glaucoma [1, 2]. The corneal opacities in patients with Peters anomaly make the diagnosis and treatment of retinal disorders such as retinopathy of prematurity (ROP) difficult.…”

Section: Introductionmentioning

confidence: 99%

Intravitreal Injection of Bevacizumab for Retinopathy of Prematurity in an Infant with Peters Anomaly

Minami¹,

Kuniyoshi²,

Sugioka³

et al. 2014

Case Rep Ophthalmol

View full text Add to dashboard Cite

Purpose: To report our findings in an infant with Peters anomaly type II whose retinopathy of prematurity (ROP) was treated with an anti-VEGF agent and surgeries. Case Report: A male infant weighing 548 g was born prematurely at 23 weeks and 1 day with corneal opacity and shallow anterior chambers in both eyes. At the postmenstrual age of 35 weeks and 3 days, the infant was tentatively diagnosed with stage 3 ROP because of a dilated tunica vasculosa lentis and ultrasonographic findings. The boy was treated with bilateral intravitreal injections of bevacizumab (IVB) because laser photocoagulation of the retina could not be performed due to the corneal opacity. The retina in the right eye detached 3 times, namely 5 days, 16 days, and 7 months after the IVB; encircling the scleral buckle and a vitrectomy with endolaser photocoagulation were therefore required. In his left eye, the retina was reattached after the initial IVB, and no additional treatment was required. ROP was not reactivated in both eyes until the last examination at the age of 2 years and 6 months. Conclusions: Our results showed that IVB is a useful treatment for ROP in patients with Peters anomaly. However, a retinal detachment can be a complication after IVB. The optimal timing of IVB for ROP in infants with hazy media needs to be determined.

show abstract

Peters Anomaly: Review of the Literature

Cited by 141 publications

References 27 publications

Demographic features of subjects with congenital glaucoma

Demographic features of subjects with congenital glaucoma

Posterior Lamellar Keratoplasty (DSAEK) in Peters Anomaly

Intravitreal Injection of Bevacizumab for Retinopathy of Prematurity in an Infant with Peters Anomaly

Contact Info

Product

Resources

About